KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesChange in InventoryDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Change in Acquisitions & Divestments (2021 - 2022)

Historic Change in Acquisitions & Divestments for BioNTech SE (BNTX) over the last 2 years, with Q4 2022 value amounting to -$17.0 million.

  • BioNTech SE's Change in Acquisitions & Divestments rose 2362.13% to -$17.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$73.9 million, marking a year-over-year change of. This contributed to the annual value of -$48.8 million for FY2022, which is 11861.69% down from last year.
  • Latest data reveals that BioNTech SE reported Change in Acquisitions & Divestments of -$17.0 million as of Q4 2022, which was up 2362.13% from -$31.4 million recorded in Q3 2022.
  • BioNTech SE's 5-year Change in Acquisitions & Divestments high stood at -$3.2 million for Q2 2022, and its period low was -$31.4 million during Q3 2022.